Spotlight Asset Group, Inc. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
Spotlight Asset Group, Inc. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,000
+22.0%
20,0000.0%0.05%
+22.7%
Q2 2023$49,200
+35042.9%
20,0000.0%0.04%
-68.3%
Q1 2023$140
-99.9%
20,0000.0%0.14%0.0%
Q3 2022$140,000
-82.3%
20,000
-33.9%
0.14%
-64.8%
Q3 2021$793,000
-18.2%
30,2650.0%0.40%
+5.9%
Q2 2021$969,000
+12.0%
30,265
+23.2%
0.37%
+14.8%
Q1 2021$865,000
+18.8%
24,565
+8.2%
0.32%
+19.9%
Q4 2020$728,00022,7090.27%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders